Cargando…

Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a shutdown of clinical research but offered a unique opportunity to understand attitudes and motivations around contributing to clinical research and resuming in-person visits during a pandemic. METHODS: We conducted an anonymous su...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsia, Daniel S., Williams, Karlie M., Beyl, Robbie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076135/
https://www.ncbi.nlm.nih.gov/pubmed/35573934
http://dx.doi.org/10.14740/jocmr4670
_version_ 1784701846062891008
author Hsia, Daniel S.
Williams, Karlie M.
Beyl, Robbie A.
author_facet Hsia, Daniel S.
Williams, Karlie M.
Beyl, Robbie A.
author_sort Hsia, Daniel S.
collection PubMed
description BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a shutdown of clinical research but offered a unique opportunity to understand attitudes and motivations around contributing to clinical research and resuming in-person visits during a pandemic. METHODS: We conducted an anonymous survey study at Pennington Biomedical Research Center (PBRC) in participants returning for in-person visits from May 26, 2020 to August 11, 2020 and in people who previously expressed interest in research via an online Research Electronic Data Capture (REDCap) survey from August 6, 2020 to September 11, 2020. The survey gathered demographic information and presented statements that required answers on a scale of 1 (absolutely disagree) to 10 (absolutely agree). Two hundred fifty-one people completed paper surveys in-person while 1,537 people completed the survey online. RESULTS: Online participants were more likely to be female (75.2% vs. 56.8%), more likely to have had COVID-19 symptoms (19.6% vs. 5.2%), and more likely to know someone with COVID-19 (72.7% vs. 49.4%). More people who came in-person thought they were low risk for severe COVID-19 compared to those who filled out the survey online (52.2% vs. 38.4%, P = 0.0002). More people who completed the survey online preferred to do as many study visits over the phone or internet as possible (37.8% vs. 22.7%, P < 0.0001). More people who came in-person agreed that clinical research is even more important than before COVID-19 (54.2% vs. 44.3%, P = 0.0035). CONCLUSIONS: The majority of people felt that clinical research is important because of the health benefits received and because it may help others. These data may provide important considerations in the planning of future studies in the era of COVID-19.
format Online
Article
Text
id pubmed-9076135
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-90761352022-05-12 Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19 Hsia, Daniel S. Williams, Karlie M. Beyl, Robbie A. J Clin Med Res Short Communication BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused a shutdown of clinical research but offered a unique opportunity to understand attitudes and motivations around contributing to clinical research and resuming in-person visits during a pandemic. METHODS: We conducted an anonymous survey study at Pennington Biomedical Research Center (PBRC) in participants returning for in-person visits from May 26, 2020 to August 11, 2020 and in people who previously expressed interest in research via an online Research Electronic Data Capture (REDCap) survey from August 6, 2020 to September 11, 2020. The survey gathered demographic information and presented statements that required answers on a scale of 1 (absolutely disagree) to 10 (absolutely agree). Two hundred fifty-one people completed paper surveys in-person while 1,537 people completed the survey online. RESULTS: Online participants were more likely to be female (75.2% vs. 56.8%), more likely to have had COVID-19 symptoms (19.6% vs. 5.2%), and more likely to know someone with COVID-19 (72.7% vs. 49.4%). More people who came in-person thought they were low risk for severe COVID-19 compared to those who filled out the survey online (52.2% vs. 38.4%, P = 0.0002). More people who completed the survey online preferred to do as many study visits over the phone or internet as possible (37.8% vs. 22.7%, P < 0.0001). More people who came in-person agreed that clinical research is even more important than before COVID-19 (54.2% vs. 44.3%, P = 0.0035). CONCLUSIONS: The majority of people felt that clinical research is important because of the health benefits received and because it may help others. These data may provide important considerations in the planning of future studies in the era of COVID-19. Elmer Press 2022-04 2022-04-23 /pmc/articles/PMC9076135/ /pubmed/35573934 http://dx.doi.org/10.14740/jocmr4670 Text en Copyright 2022, Hsia et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Hsia, Daniel S.
Williams, Karlie M.
Beyl, Robbie A.
Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19
title Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19
title_full Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19
title_fullStr Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19
title_full_unstemmed Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19
title_short Participant Perspectives Concerning Resuming Clinical Research in the Era of COVID-19
title_sort participant perspectives concerning resuming clinical research in the era of covid-19
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076135/
https://www.ncbi.nlm.nih.gov/pubmed/35573934
http://dx.doi.org/10.14740/jocmr4670
work_keys_str_mv AT hsiadaniels participantperspectivesconcerningresumingclinicalresearchintheeraofcovid19
AT williamskarliem participantperspectivesconcerningresumingclinicalresearchintheeraofcovid19
AT beylrobbiea participantperspectivesconcerningresumingclinicalresearchintheeraofcovid19